• The first half of 2024 was strong as M&As and financings dominate

  • Jul 26 2024
  • Length: 18 mins
  • Podcast

The first half of 2024 was strong as M&As and financings dominate

Listen for free

View show details

  • Summary

  • Karen Carey, BioWorld managing editor and chief analyst, takes a look at the numbers from the first half of 2024. She finds the first six months to be healthy for the biopharma market while the rest of the year is populated with question marks that include the U.S. presidential election and potential interest rate cuts.
    Show more Show less
Show more Show less

What listeners say about The first half of 2024 was strong as M&As and financings dominate

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available